25K fundamentals
An in-depth look to KARYOPHARM THERAPE operating, investing, and financing activities
25K free cash flow for Q3 24 is -16.49 M CHF. For 2023, 25K free cash flow was -78.07 M CHF and operating cash flow was -78.07 M CHF.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CHF
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM